Spots Global Cancer Trial Database for stereotactic radiosurgery (srs)
Every month we try and update this database with for stereotactic radiosurgery (srs) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases | NCT03497767 | Metastatic Non ... | Osimertinib Stereotactic Ra... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases | NCT01731704 | Brain Metastase... | Stereotactic ra... Whole brain rad... | 18 Years - | University of California, San Francisco | |
| A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS) | NCT01821443 | Brain Metastase... | Stereotactic ra... | 18 Years - | University of California, San Francisco | |
| A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases | NCT05341739 | Brain Metastase... | Pre-operative S... | 18 Years - | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | |
| Perfexion Brain Metastasis | NCT00805103 | Brain Metastase... | Hypofractionate... | 18 Years - | University Health Network, Toronto | |
| Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis | NCT03483012 | Breast Cancer | Atezolizumab Stereotactic ra... | 18 Years - | Dana-Farber Cancer Institute | |
| A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS) | NCT01821443 | Brain Metastase... | Stereotactic ra... | 18 Years - | University of California, San Francisco | |
| Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases | NCT01731704 | Brain Metastase... | Stereotactic ra... Whole brain rad... | 18 Years - | University of California, San Francisco | |
| Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy | NCT05703269 | NSCLC Renal Cell Carc... Breast Carcinom... Melanoma Brain Metastase... Non-small Cell ... SCLC Small-cell Lung... | single fraction... fractionated st... | 18 Years - | Wake Forest University Health Sciences | |
| Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases | NCT03775330 | Brain Metastase... | Stereotactic Ra... Whole brain rad... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence | NCT03303365 | Brain Metastase... Adult Solid Tum... | stereotactic ra... | 18 Years - | University Hospital Heidelberg | |
| A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases | NCT03497767 | Metastatic Non ... | Osimertinib Stereotactic Ra... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases | NCT03550391 | Brain Metastase... | Memantine Hippocampal-avo... Stereotactic Ra... | 18 Years - | Canadian Cancer Trials Group | |
| A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases | NCT05341739 | Brain Metastase... | Pre-operative S... | 18 Years - | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | |
| Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases | NCT01731704 | Brain Metastase... | Stereotactic ra... Whole brain rad... | 18 Years - | University of California, San Francisco | |
| Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform | NCT01120639 | Glioblastoma Cancer of Brain... Glioblastoma Mu... | Temozolomide Stereotactic Ra... | 18 Years - | Stanford University | |
| Radiosurgery and Avastin for Recurrent Malignant Gliomas | NCT01017250 | Malignant Gliom... | Stereotactic Ra... Bevacizumab | 18 Years - 80 Years | Duke University | |
| Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma | NCT01703507 | Recurrent Melan... Stage IV Melano... Tumors Metastat... | Ipilimumab Whole-Brain Rad... Stereotactic Ra... | 18 Years - | Thomas Jefferson University | |
| MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases | NCT04246879 | Brain Metastase... | MRI | 18 Years - | Duke University | |
| Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases | NCT02320825 | Spinal Metastas... | single-fraction... high-dose hypof... Quality of Life... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases | NCT03775330 | Brain Metastase... | Stereotactic Ra... Whole brain rad... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases | NCT02320825 | Spinal Metastas... | single-fraction... high-dose hypof... Quality of Life... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases | NCT04923542 | Brain Metastase... HR+ Metastatic ... | Stereotactic Ra... Abemaciclib Endocrine thera... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform | NCT01120639 | Glioblastoma Cancer of Brain... Glioblastoma Mu... | Temozolomide Stereotactic Ra... | 18 Years - | Stanford University | |
| Perfexion Brain Metastasis | NCT00805103 | Brain Metastase... | Hypofractionate... | 18 Years - | University Health Network, Toronto | |
| A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain | NCT06132945 | Metastatic Rena... Brain Metastase... | Cabozantinib Nivolumab Stereotactic Ra... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform | NCT01120639 | Glioblastoma Cancer of Brain... Glioblastoma Mu... | Temozolomide Stereotactic Ra... | 18 Years - | Stanford University | |
| A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases | NCT05341739 | Brain Metastase... | Pre-operative S... | 18 Years - | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | |
| Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) | NCT01130766 | Non-small Cell ... | stereotactic ra... | 18 Years - | Samsung Medical Center | |
| Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma | NCT04474353 | Glioblastoma Newly Diagnosed... | Optune Gadolinium Temozolomide Stereotactic ra... | 18 Years - | Stanford University | |
| Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases | NCT03775330 | Brain Metastase... | Stereotactic Ra... Whole brain rad... | 18 Years - | Sunnybrook Health Sciences Centre |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
